Universitätsklinikum Schleswig-Holstein (UKSH)

Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease (2022) Grueter T, Moellers FE, Tietz A, Dargvainiene J, Melzer N, Heidbreder A, Strippel C, et al. Journal article Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study (2022) Middeke JM, Metzeler KH, Rollig C, Kramer M, Eckardt JN, Stasik S, Greif PA, et al. Journal article Graphene Oxide Framework Structures and Coatings: Impact on Cell Adhesion and Pre-Vascularization Processes for Bone Grafts (2022) Wang F, Saure LM, Schuett F, Lorich F, Rasch F, Nia AS, Feng X, et al. Journal article Endothelial Retargeting of AAV9 In Vivo (2022) Bozoglu T, Lee S, Ziegler T, Jurisch V, Maas S, Baehr A, Hinkel R, et al. Journal article Do obstetric units adhere to the evidence-based national guideline? A Germany-wide survey on the current practice of initial tocolysis (2022) Stelzl P, Kehl S, Oppelt P, Maul H, Enengl S, Kyvernitakis I, Rath W Journal article Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry (2022) Stoelzl D, Boraczynski N, Heratizadeh A, Haufe E, Harder I, Abraham S, Heinrich L, et al. Conference contribution Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy (2022) Beckmann M, Stübs F, Koch M, Mallmann P, Dannecker C, Dietl A, Sevnina A, et al. Journal article S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) (2022) Helbig D, Ziemer M, Dippel E, Erdmann M, Hillen U, Leiter U, Mentzel T, et al. Journal article S3-Leitlinie: Diagnostik und Therapie biliärer Karzinome (2022) Bitzer M, Voesch S, Albert J, Bartenstein P, Bechstein W, Blödt S, Brunner T, et al. Journal article S3 Guideline - Diagnosis and treatment of biliary carcinomas: Long version 2.0 - June 2021 - AWMF Register No.: 032-053OL S3-Leitlinie - Diagnostik und Therapie biliärer Karzinome (2022) Bitzer M, Voesch S, Albert J, Bartenstein P, Bechstein W, Blödt S, Brunner T, et al. Journal article